NCT01755689 / 2012-001876-13: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Meningococcal Vaccine With or Without Co-administration of Cervarix and Boostrix in Female Adolescents and Young Adults |
|
|
| Completed | 3 | 1300 | Europe, RoW | Meningococcal vaccine GSK134612, Nimenrix®, Cervarix®, Boostrix® | GlaxoSmithKline | Infections, Meningococcal | 04/14 | 04/14 | | |
